Congressional Pressure Mounts As Tariff Authorities Shift

Lawmakers on Capitol Hill have expressed growing concerns about the Trump Administration’s tariff strategy and its impact on the nation’s medical supply chain.

During a recent congressional hearing with U.S. Trade Representative Jamieson Greer, Rep. Nicole Malliotakis (R‑NY) advocated for the Medical Supply Chain Resiliency Act. The legislation would give the Trump Administration tools to “establish trusted trade partnerships with reliable allies to eliminate tariffs and trade barriers.” Ambassador Greer acknowledged that such congressional tools “could be helpful” as part of efforts to support reshoring and supply chain security.

Watch: Clip of Rep. Malliotakis’ Remarks

Similarly, Rep. Mike Carey (R‑OH) underscored that “exempting medical supplies from trusted trading partners is critical” to ensuring providers have access to cost‑effective, life‑saving devices, and pressed USTR to prevent further tariff‑related cost increases.

Watch: Clip of Rep. Carey’s Remarks

Congress’s heightened engagement comes at a moment when the foundation for tariff policy is shifting and new duties are under active consideration.

“Exempting medical supplies from trusted trading partners is critical.”

Rep. Mike Carey (R‑OH)
U.S. House of Representatives